Axonics to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Axonics, a global medical technology company, will participate in two upcoming investor conferences. The first is the BofA Securities Healthcare Conference on May 9 at 2:20 p.m. ET, followed by the RBC Capital Markets Healthcare Conference on May 16 at 4:05 p.m. ET. Interested investors can access live webcasts and replays on the Axonics investor relations website.

Axonics focuses on developing products for bladder and bowel dysfunction and has been recognized for rapid growth, ranking No. 2 in the 2023 Financial Times and No. 4 in the 2022 Deloitte Technology Fast 500.

IRVINE, Calif.--(BUSINESS WIRE)-- Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, is scheduled to participate in the following upcoming investor conferences:

Event: BofA Securities Healthcare Conference
Date: Tuesday, May 9
Time: 2:20 p.m. Eastern Time

Event: RBC Capital Markets Healthcare Conference
Date: Tuesday, May 16
Time: 4:05 p.m. Eastern Time

Interested parties may access a live webcast and replay of each presentation by visiting the Axonics investor relations website.

About Axonics

Axonics is a global medical technology company that is developing and commercializing novel products for adults with bladder and bowel dysfunction. Axonics recently ranked No. 2 on the 2023 Financial Times ranking of the fastest growing companies in the Americas and No. 4 on the 2022 Deloitte Technology Fast 500.

Axonics^® sacral neuromodulation systems provide adults with overactive bladder and/or fecal incontinence with long-lived, easy to use, safe, clinically effective therapy. In addition, the company’s best-in-class urethral bulking hydrogel, Bulkamid^®, provides safe and durable symptom relief to women with stress urinary incontinence. In the U.S., moderate to severe urinary incontinence affects an estimated 28 million women and fecal incontinence affects an estimated 19 million adults. Axonics’ clinically proven products are offered at hundreds of medical centers across the U.S. and abroad. Reimbursement coverage is well established in the U.S. and is a covered service in most European countries. For more information, visit www.axonics.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230425005084/en/

Axonics contact:

Neil Bhalodkar

949-336-5293

IR@axonics.com

Source: Axonics, Inc.

FAQ

What are the dates for Axonics' upcoming investor conferences?

Axonics will participate in the BofA Securities Healthcare Conference on May 9 and the RBC Capital Markets Healthcare Conference on May 16.

What time will Axonics present at the BofA Securities Healthcare Conference?

Axonics will present at the BofA Securities Healthcare Conference at 2:20 p.m. Eastern Time on May 9.

How can I access Axonics' conference presentations?

You can access the live webcasts and replays of Axonics' presentations on their investor relations website.

What position did Axonics rank in the Financial Times fastest growing companies list?

Axonics ranked No. 2 in the 2023 Financial Times ranking of the fastest growing companies in the Americas.

What is the focus of Axonics as a medical technology company?

Axonics is focused on developing and commercializing products for the treatment of bladder and bowel dysfunction.